"Aged, 80 and over" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person 80 years of age and older.
| Descriptor ID |
D000369
|
| MeSH Number(s) |
M01.060.116.100.080
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aged, 80 and over".
Below are MeSH descriptors whose meaning is more specific than "Aged, 80 and over".
This graph shows the total number of publications written about "Aged, 80 and over" by people in this website by year, and whether "Aged, 80 and over" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 49 | 49 |
| 1995 | 0 | 52 | 52 |
| 1996 | 0 | 72 | 72 |
| 1997 | 0 | 67 | 67 |
| 1998 | 0 | 61 | 61 |
| 1999 | 0 | 50 | 50 |
| 2000 | 0 | 73 | 73 |
| 2001 | 0 | 72 | 72 |
| 2002 | 0 | 85 | 85 |
| 2003 | 0 | 94 | 94 |
| 2004 | 0 | 106 | 106 |
| 2005 | 0 | 124 | 124 |
| 2006 | 0 | 114 | 114 |
| 2007 | 0 | 140 | 140 |
| 2008 | 0 | 201 | 201 |
| 2009 | 0 | 169 | 169 |
| 2010 | 0 | 196 | 196 |
| 2011 | 0 | 234 | 234 |
| 2012 | 0 | 220 | 220 |
| 2013 | 0 | 245 | 245 |
| 2014 | 0 | 244 | 244 |
| 2015 | 0 | 267 | 267 |
| 2016 | 0 | 263 | 263 |
| 2017 | 0 | 245 | 245 |
| 2018 | 0 | 259 | 259 |
| 2019 | 0 | 268 | 268 |
| 2020 | 0 | 241 | 241 |
| 2021 | 0 | 188 | 188 |
| 2022 | 0 | 34 | 34 |
| 2023 | 0 | 36 | 36 |
| 2024 | 0 | 168 | 168 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aged, 80 and over" by people in Profiles.
-
Clinical Utility of a Circulating Tumor Cell-Based Cerebrospinal Fluid Assay in the Diagnosis and Molecular Analysis of Leptomeningeal Disease in Patients With Advanced Non-Small Cell Lung Cancer. JCO Precis Oncol. 2024 Dec; 8:e2400373.
-
Osimertinib-induced DNA resistance mutations in cerebrospinal fluid of epidermal growth factor receptor-mutated non-small-cell lung carcinoma patients developing leptomeningeal metastases: Osimertinib Resistance Analysis-leptomeningeal metastases study. Neuro Oncol. 2024 Dec 05; 26(12):2316-2327.
-
Blast Phase of Myeloproliferative Neoplasm Resembles Acute Myeloid Leukemia, Myelodysplasia-Related, in Clinical Presentation, Cytogenetic Pattern, and Genomic Profile, and Often Undergoes Reversion to Second Chronic Phase Status After Induction Chemotherapy. Arch Pathol Lab Med. 2024 Dec 01; 148(12):1310-1319.
-
Ventral Hernia Repair With a Hybrid Absorbable-permanent Preperitoneal Mesh. Surg Laparosc Endosc Percutan Tech. 2024 Dec 01; 34(6):596-602.
-
A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosis. Blood Adv. 2024 Nov 26; 8(22):5735-5743.
-
Indeterminate DC histiocytosis is distinct from LCH and often associated with other hematopoietic neoplasms. Blood Adv. 2024 Nov 26; 8(22):5796-5805.
-
Mechanical thrombectomy for the treatment of primary and secondary anterior cerebral artery occlusions: insights from STAR. J Neurointerv Surg. 2024 Nov 22; 16(12):1282-1287.
-
Outcomes of mechanical thrombectomy in stroke patients with extreme large infarction core. J Neurointerv Surg. 2024 Nov 22; 16(12):1268-1274.
-
Primary results from the CLEAR study of a novel stent retriever with drop zone technology. J Neurointerv Surg. 2024 Nov 22; 16(12):1220-1227.
-
Genetic risk stratification and outcomes among treatment-naive patients with AML treated with venetoclax and azacitidine. Blood. 2024 Nov 21; 144(21):2211-2222.